Explanation
Oraladministration
Capecitabineisaprodrugof5-fuuorouracit(5-FU).tsmajor advantageiswithrespect toorauadministration,
versus IVadministrationfor5-FU.Theadministrationof5-FUreauiresacentralvenous access devicetobe
insertedeqHickmanune)throuahwhicha48-hinfusionisaivenevery fortniaht.Capecitabineorattabletsare
takentwicedait.reducinathenumber of hospitalvisits andinvasiveprocedures reauired for oncoloay
batients.
Giventhat5-FUistheactivemetabotiteof capecitabine.half-lfe,toxicity, elimination and volumeof
distribution areessentialythesame.Dataoneffcacyare broaduy similarfor 5-FU and capecitabine.Toxicities
includeneutropaenia,diarrhoea,hand-foot syndromeand.rarely,coronary vasospasm.Patient educationi
cruciaLwhenadministering oratchemotherapy inorderto prevemt patientsfromcontinuingtreatmemt without
seekinqmedicauadvice inthefaceof severetoxicity.
@1MINNDOCRINE
